Korea Herbalife’s exclusive genetic analysis service ‘Gene Start+’, jointly developed by Theragen Bio, an artificial intelligence (AI)-based new drug development company, and Korea Herbalife, was renewed four years after its launch in 2018. Detailed inspection items were also greatly expanded from 10 to 41.
This newly upgraded ZenStart Plus has been renewed with user convenience as the top priority. Genetic test items are broadly divided into eight areas, including obesity management, vitamin management, blood vessel health, mineral management, musculoskeletal management, nutrient management, eating habits management, and skin and hair management, and the detailed test items have increased from the existing 10 to 41. It has expanded.
The method of checking test results has also become simpler. Previously, test results had to be checked through a booklet, but with the introduction of a mobile app, results can be checked anytime, anywhere.
Herbalife Korea received attention in 2018 by introducing GenStart, a genetic testing service jointly developed with Theragen Bio. Based on genetic testing for various items such as body mass index, neutral fat concentration, cholesterol, blood sugar, and blood pressure using an easy-to-use genetic testing kit, and the results of a dietary habit questionnaire, health functional foods such as health management guidelines and Herbalife Nutrition product recommendations are provided. and provided more realistic and effective consulting.
Taesoon Hwang, CEO of Theragen Bio, said, “As the ‘Healthy Pleasure’ trend, which means managing one’s health in a fun way, is popular among all age groups, the goal of health management is also shifting from ‘treatment’ to ‘prevention.’ “In the future, the market for customized solutions for effective health management for each individual will also expand,” he said. “We will spare no effort across the company to ensure that Genstart Plus can be reborn as a global gene-based customized health management service in the future.”
Meanwhile, Theragen Bio became the world’s fifth company and the first company in Korea to successfully analyze personal genomes, and became the first company in Asia to commercialize a personalized genetic analysis service in 2010. Currently, we provide genome analysis services to over 700 domestic medical institutions and research institutions in over 40 countries.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asian Innovation Hub Pangyo Techno Valley 2022’ news